Northeastern Taiwan Community Medicine Research Cohort
NTCMRC
A Cohort Study on Disease Prevention and Health Promotion in Northeastern Region of Taiwan
1 other identifier
observational
20,000
1 country
1
Brief Summary
The cohort study on disease prevention and health promotion in the northeastern region of Taiwan is a trial dedicated to large-scale generational research in northeastern Taiwan beginning in the August of 2013. The program aims to develop a comprehensive and integrated approach to disease prevention and community health. The researcher's cohort organizes healthcare outreaches for participants over the age of 20 residing in 64 administrative areas in Keelung city and new Taipei city. The researcher's sessions include a comprehensive health examination, health-related questionnaires, and disease awareness seminars. Biological samples, questionnaire information, and medical data obtained from researcher's participants are stored in researcher's core laboratory. Depersonalized data and samples are shared with partnering trials approved by the Chang Gung Memorial Hospital Institutional review board. The investigators are currently partnered with 18 clinical trials spanning across multiple disciplines such as urology, hepatology, metabolism, physical therapy, and psychology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2013
CompletedFirst Submitted
Initial submission to the registry
March 28, 2021
CompletedFirst Posted
Study publicly available on registry
April 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2043
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2043
April 9, 2021
January 1, 2021
30 years
March 28, 2021
April 7, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Participant died during the observation period.
Investigators keep in touch with participants and invite them to participate in healthcare outreaches every year.
From 2013 Augus to Feb 2021
Dementia
The AD8 dementia screening interview is used to detect the early signs of dementia. Using the items in the form to check whether participants have similar symptoms, so as to detect and treat them as soon as possible.
From 2013 Augus to Feb 2021
Chronic Kidney Disease
Chronic kidney disease is a type of kidney disease in which there is gradual loss of kidney function over a period of months to years.
From 2013 Augus to Feb 2021
Liver cancer
Participant suffers from liver cancer
From 2013 Augus to Feb 2021
Study Arms (2)
Participants residing in urban areas
Urban residents enjoy convenient transportation, have access to abundant medical resources, have more job opportunities, and are on average younger but are also exposed to more air pollution.
Participants residing in rural areas
Rural residents have less access to transportation, medical resources, and job prospects comparatively and are comparatively older. However, Rural residents are exposed to less pollution in general.
Eligibility Criteria
Participants who enroll in these community health activities and meet the following conditions: 1. Over the age of 20. 2. Residing in 64 administrative areas in Keelung city and new Taipei city.
You may qualify if:
- Residing in Keelung city and new Taipei city.
- Mobile health and mental health
- Participating in healthcare outreaches
You may not qualify if:
- Under 20 years old
- Participant without judgment
- Participant has HIV
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Community Medicine Research Center Chang Gung Memorial Hospital Keelung,Taiwan,204
Keelung, Taiwan
Related Publications (3)
Hsu PW, Yeh CH, Lo CJ, Tsai TH, Chan YH, Chou YJ, Yang NI, Cheng ML, Sheu WH, Lai CC, Sytwu HK, Tsai TF. Trans-omics analyses identify the biochemical network of LPCAT1 associated with coronary artery disease. Biomark Res. 2025 Aug 20;13(1):107. doi: 10.1186/s40364-025-00821-y.
PMID: 40830908DERIVEDWei YC, Chen CK, Lin C, Shyu YC, Chen PY. Life After Traumatic Brain Injury: Effects on the Lifestyle and Quality of Life of Community-Dwelling Patients. Neurotrauma Rep. 2024 Mar 1;5(1):159-171. doi: 10.1089/neur.2023.0113. eCollection 2024.
PMID: 38463415DERIVEDWu IW, Tsai TH, Lo CJ, Chou YJ, Yeh CH, Cheng ML, Lai CC, Sytwu HK, Tsai TF. Discovery of a Biomarker Signature That Reveals a Molecular Mechanism Underlying Diabetic Kidney Disease via Organ Cross Talk. Diabetes Care. 2022 Jun 2;45(6):e102-e104. doi: 10.2337/dc22-0145. No abstract available.
PMID: 35546525DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Yu Chiau Shyu, PHD
Community Medicine Research Center,Chang Gung Memorial Hospital,Keelung branch
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 28, 2021
First Posted
April 9, 2021
Study Start
August 1, 2013
Primary Completion (Estimated)
August 1, 2043
Study Completion (Estimated)
August 1, 2043
Last Updated
April 9, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share